TY - JOUR
T1 - Protein interactome of muscle invasive bladder cancer
AU - Bhat, Akshay
AU - Heinzel, Andreas
AU - Mayer, Bernd
AU - Perco, Paul
AU - Mühlberger, Irmgard
AU - Husi, Holger
AU - Merseburger, Axel S.
AU - Zoidakis, Jerome
AU - Vlahou, Antonia
AU - Schanstra, Joost P.
AU - Mischak, Harald
AU - Jankowski, Vera
N1 - Publisher Copyright:
© 2015 Bhat et al.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2015/1/8
Y1 - 2015/1/8
N2 - Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to provide 286 unique protein-coding genes. These were integrated in a protein-interaction network to obtain a molecular functional map of the phenotype. This feature map educated on three novel disease-associated pathways with plausible involvement in bladder cancer, namely Regulation of actin cytoskeleton, Neurotrophin signalling pathway and Endocytosis. Systematic integration approaches allow to study the molecular context of individual features reported as associated with a clinical phenotype and could potentially help to improve the molecular mechanistic description of the disorder.
AB - Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to provide 286 unique protein-coding genes. These were integrated in a protein-interaction network to obtain a molecular functional map of the phenotype. This feature map educated on three novel disease-associated pathways with plausible involvement in bladder cancer, namely Regulation of actin cytoskeleton, Neurotrophin signalling pathway and Endocytosis. Systematic integration approaches allow to study the molecular context of individual features reported as associated with a clinical phenotype and could potentially help to improve the molecular mechanistic description of the disorder.
UR - http://www.scopus.com/inward/record.url?scp=84920771366&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0116404
DO - 10.1371/journal.pone.0116404
M3 - Journal articles
C2 - 25569276
AN - SCOPUS:84920771366
VL - 10
JO - PLoS ONE
JF - PLoS ONE
IS - 1
M1 - e0116404
ER -